Nova Biomedical StatStrip Glucose Meter Wrong Patient Blood Sugar Results Injury Lawsuit Lawyers

FDA Class I Recall Raises Concerns About Insulin Overdoses, Dangerous Blood Sugar Changes, Hospital Patient Identification Errors, and Potential Medical Device Injury Lawsuits.

What Parker Waichman LLP Found

• Serious safety classification: The FDA assigned the StatStrip Gen 2.0 recall its highest risk classification because patient identification errors may cause serious injury or death.
• Documented injury: The FDA reported one serious injury and no deaths as of October 5, 2026.
• Medication risks: Incorrectly assigned glucose results may lead to unnecessary insulin, delayed treatment, or dangerous blood sugar changes.
• Potential legal claims: Injured patients may have product liability or medical malpractice claims depending on the evidence.
• Important evidence: Glucose records, medication logs, device identification, and electronic chart audit trails may help establish what happened.

A hospital blood glucose test can determine whether a patient receives insulin, emergency glucose treatment, or additional medical monitoring. Doctors and nurses depend on these results to make treatment decisions, particularly when caring for critically ill patients, people with diabetes, and newborns in intensive care units. When a glucose test result is assigned to the wrong patient, an otherwise accurate measurement can lead to a dangerous medical decision. Patients may receive medication they do not need, while others may be denied treatment necessary to prevent serious complications.

The U.S. Food and Drug Administration (FDA) has classified a recall involving Nova Biomedical’s StatStrip Glucose Hospital Meter System as Class I, its most serious recall classification. According to the FDA’s October 20, 2026, notice, certain hospital glucose meters may incorrectly associate blood sugar readings with another patient’s medical record. The agency warns that continued use of affected devices could result in serious injury or death.

The recall involves StatStrip Gen 2.0 hospital glucose meters, including part numbers 63685 and 66739, across all serial numbers and software versions. Earlier generations are not included in this particular recall. Although Nova Biomedical maintains that the devices can accurately measure glucose, the software-related patient identification problem creates substantial risks when medical professionals rely on incorrectly assigned results.

As of October 5, 2026, the FDA reported one serious injury and no deaths associated with the problem. The incident highlights how a patient identification failure involving medical technology can potentially cause preventable injuries and raise questions about product safety, hospital procedures, and legal responsibility.

How the StatStrip Glucose Meter Software Problem Can Cause Patient Identification Errors

The reported malfunction involves how the glucose meter handles patient identification information during bedside testing. Hospital personnel ordinarily scan a patient’s identification barcode before obtaining a blood glucose measurement. This process links the test result to the correct electronic medical record and lets clinicians review the information when making treatment decisions.

According to the FDA, the affected Gen 2.0 meters may retain information from a previous patient identification or quality control barcode scan. If a healthcare worker accepts the information displayed without recognizing that it belongs to another patient, the next glucose reading may be saved under an incorrect identification number.

This error can have consequences beyond a single incorrect chart entry. Hospital electronic records are often accessed by multiple clinicians, and glucose readings may influence medication administration, treatment adjustments, and decisions about whether a patient requires additional testing. Once incorrect information enters a patient’s medical record, other healthcare professionals may unknowingly rely on it.

Importantly, the recall does not establish that the meters are producing inaccurate glucose measurements. The central problem is that a valid measurement may be assigned to someone who was never tested. This distinction matters because ordinary equipment accuracy checks may not identify a patient identification error.

How Incorrect Blood Sugar Results Can Cause Serious Injuries or Death

Blood glucose levels must remain within a medically appropriate range for the body to function properly. Insulin lowers blood sugar, while glucose administration and other interventions may be necessary when blood sugar becomes dangerously low. Giving treatment based on another patient’s reading can disrupt this balance and expose patients to avoidable medical emergencies.

Inappropriate Insulin Administration and Severe Hypoglycemia

One of the most concerning risks involves administering insulin to a patient whose actual blood glucose level does not justify the medication. If an incorrectly assigned reading indicates high blood sugar, clinicians may administer insulin even though the patient’s true glucose level is normal or already low.

Excessive insulin can cause hypoglycemia, a condition in which blood sugar falls below a safe level. Severe hypoglycemia may result in confusion, seizures, loss of consciousness, neurological injury, or death. Patients who are sedated, unconscious, or unable to communicate may be particularly vulnerable because they cannot easily alert medical personnel to developing symptoms.

Delayed Treatment for Dangerous Blood Sugar Levels

Incorrectly assigned readings can also prevent patients from receiving necessary treatment. A person experiencing significant hyperglycemia may have a normal glucose value incorrectly recorded in their chart, potentially delaying insulin administration or further evaluation.

Untreated severe hyperglycemia can contribute to diabetic ketoacidosis or hyperosmolar hyperglycemic state in susceptible patients. Both conditions may become life-threatening without timely intervention. Similarly, an actual low blood sugar reading that is attributed to another patient may prevent the correct patient from receiving urgently needed glucose.

Increased Risks for Intensive Care Patients and Newborns

Patients in intensive care units frequently undergo repeated blood glucose testing because serious illness, medications, nutritional support, and other medical conditions can cause rapid fluctuations. Some patients require carefully adjusted insulin infusions, making accurate patient identification essential.

Newborns receiving treatment in neonatal intensive care units may also face substantial risks from missed or inappropriate glucose treatment. Infants cannot describe symptoms, and prolonged or severe hypoglycemia may cause seizures or neurological complications. A patient identification error affecting these vulnerable populations may therefore have particularly serious consequences.

What the FDA Found About Reported Injuries and Customer Complaints

Nova Biomedical initially notified customers about the issue on July 31, 2026, and issued a revised communication on October 5, 2026. The manufacturer reported receiving 71 customer complaints involving the scanning problem.

The company also described a U.S. adverse event reported on July 17 in which a patient received inappropriate insulin based on another patient’s glucose result. Although Nova’s notice stated that no serious adverse events had been reported, the FDA subsequently identified one serious injury as of October 5.

These descriptions should not be treated as proof of additional injuries beyond those reported. However, the incident demonstrates the potential for a software identification error to progress from an incorrect medical record entry to inappropriate medication administration.

The FDA’s Class I designation reflects the possibility that continued use of affected devices could cause serious adverse health consequences or death. It does not mean every affected meter has malfunctioned or that every patient tested with one suffered an injury.

Which StatStrip Glucose Meters Are Affected by the Recall?

The current recall applies specifically to Nova Biomedical StatStrip Glucose Hospital Meter System Gen 2.0 devices with part numbers 63685 and 66739. All serial numbers and software versions within those affected models are included.

Earlier StatStrip generations, including versions 1.0, 1.75, 1.86, and 1.87, are not covered by this particular recall. The notice also does not involve ordinary home-use blood glucose meters.

Nova Biomedical has placed a shipment hold on new Gen 2.0 meters and announced plans for a phased software update beginning in November 2026. The FDA recommends removing affected meters from use until the corrective update becomes available.

For facilities unable to immediately substitute another device, the FDA describes additional safeguards, including patient identification validation where supported, automatic user logout after testing, and repeated verification of patient information. Hospitals must also promptly address results discovered in the wrong medical record.

Who May Qualify to File a StatStrip Glucose Meter Injury Lawsuit?

Patients who experienced preventable injuries after receiving treatment based on incorrectly assigned glucose readings may have grounds to investigate a medical device product liability claim, a medical malpractice claim, or both.

Potential claims depend on the circumstances surrounding the incident, the nature of the injury, and the laws governing the case. A recall alone does not establish that a manufacturer or healthcare provider is legally responsible for an individual patient’s injuries.

Potential Product Liability Claims Against the Manufacturer

A product liability investigation may examine whether a software design defect, inadequate warnings, insufficient testing, or another product-related failure contributed to a patient’s injury.

Attorneys may review the manufacturer’s recall communications, device records, software information, and other evidence to determine whether the manufacturer knew or should have known about a dangerous condition. Depending on applicable law, claims may involve negligence, defective design, or failure to warn.

Potential Medical Malpractice Claims Against Healthcare Providers

Some incidents may also involve questions about whether hospital personnel followed appropriate patient identification and medication administration procedures.

A malpractice investigation may consider whether clinicians verified the correct patient before testing, recognized inconsistent glucose readings, followed applicable safety instructions, and responded appropriately after discovering an error. Hospital responsibility depends on the facts and applicable professional standards, not simply on the presence of a recalled device.

Compensation for Patients Injured by Incorrect Glucose Treatment

When legally supported, compensation may include medical expenses, additional hospitalization, rehabilitation, lost income, diminished earning capacity, and physical pain and suffering.

Patients with permanent neurological injuries may require long-term medical care, assistance with daily activities, or other support. If a patient dies because of a preventable medical device-related injury, eligible surviving family members or estate representatives may be able to pursue a wrongful death or survival claim under applicable state law.

What Patients and Families Should Do After a Suspected Glucose Meter Injury

Patients who believe an incorrect glucose reading contributed to an injury should first ensure that the treating medical team knows about the concern. A suspected patient identification error may require immediate clinical evaluation, correction of medical records, and additional testing to determine whether inappropriate treatment occurred.

Patients and authorized family members can request relevant medical records, including glucose test results, insulin administration records, laboratory findings, and documentation identifying the equipment used. They should preserve any discharge instructions, medical bills, and written communications concerning the incident.

Because electronic medical records may contain audit trails and device-generated data, an attorney may seek preservation of additional evidence before information becomes unavailable through routine retention practices.

Suspected medical device problems can also be reported through the FDA’s MedWatch reporting program. Reporting a problem does not replace medical treatment or preserve a patient’s legal filing deadline.

StatStrip Glucose Meter Recall Lawsuit FAQs

Can I Sue Nova Biomedical if a Recalled StatStrip Glucose Meter Caused My Injury?

You may have grounds for a lawsuit if an affected StatStrip Gen 2.0 meter contributed to an incorrect treatment decision that caused a documented injury. A product liability claim may examine whether defective software, inadequate warnings, or another product safety failure caused the harm. Establishing liability generally requires evidence connecting the device malfunction to the treatment and resulting injury. An attorney can review the medical records, device information, and applicable law to evaluate whether a claim is appropriate.

Can I File a Lawsuit if a Hospital Gave Me Too Much Insulin Because of an Incorrect Glucose Reading?

Potentially. If a hospital administered inappropriate insulin because another patient’s glucose result appeared in your medical record, you may have grounds to investigate a claim. Important evidence includes medication administration records, actual glucose measurements, nursing notes, and documentation of complications. Depending on the circumstances, legal responsibility could involve the device manufacturer, healthcare providers, or multiple parties. The investigation must establish whether the incorrect treatment caused an identifiable injury.

What Injuries May Support a StatStrip Glucose Meter Lawsuit?

Potential injuries include severe hypoglycemia, seizures, loss of consciousness, neurological damage, and complications requiring emergency treatment or extended hospitalization. Other claims may involve injuries caused by delayed treatment of dangerously elevated or reduced glucose levels. The severity of the injury, necessary medical care, and long-term consequences can influence potential compensation. Not every glucose irregularity establishes a compensable injury, so medical documentation and causation are important.

Can Families File a Lawsuit if a Newborn Was Injured by an Incorrect Blood Sugar Result?

Parents or legal guardians may be able to pursue claims on behalf of newborns who suffered injuries associated with incorrect glucose treatment. These cases may involve seizures, neurological complications, developmental concerns, or prolonged hospitalization. Medical records, laboratory results, medication administration information, and appropriate medical evaluations may help determine whether a device-related error contributed to the injury. Filing procedures and deadlines involving minors vary by state.

How Long Do I Have to File a StatStrip Glucose Meter Injury Lawsuit?

Filing deadlines depend on the state, the type of claim, and the circumstances surrounding the injury. Product liability and medical malpractice cases may have different statutes of limitations, notice requirements, or other procedural restrictions. Some deadlines may be affected by when an injury was discovered, while others may be subject to statutes of repose. Because important evidence can also become harder to obtain over time, patients should seek a legal evaluation promptly rather than assume the recall extends their filing deadline.

Free Consultation With Parker Waichman LLP About StatStrip Glucose Meter Injuries

Patients who suffered serious complications after receiving inappropriate insulin or delayed glucose treatment deserve answers about what happened and whether the injury could have been prevented. Parker Waichman LLP is a national personal injury law firm that represents people harmed by allegedly defective medical devices and other dangerous products.

Our attorneys can investigate potential claims involving recalled StatStrip glucose meters, review relevant medical evidence, and evaluate whether a manufacturer or healthcare provider may bear legal responsibility.

Call Parker Waichman LLP at 1-800-YOUR-LAWYER (1-800-968-7529) for a free consultation. We can discuss your circumstances, explain potential legal options, and determine whether further investigation is warranted. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.